» Articles » PMID: 28267785

Smad3-dependent CCN2 Mediates Fibronectin Expression in Human Skin Dermal Fibroblasts

Overview
Journal PLoS One
Date 2017 Mar 8
PMID 28267785
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The potential involvement of connective tissue growth factor (CCN2/CTGF) in extracellular matrix (ECM) production is recognized. However, the role CCN2 in fibronectin (FN) gene expression has remained incompletely understood and even controversial. Here we report that CCN2 is absolutely necessary for FN expression in primary human skin dermal fibroblasts, the major cells responsible for ECM production in skin. Gain- and loss-of-function approaches demonstrate that CCN2 is an essential component of FN expression in both basal and stimulation by TGF-β signaling, the major regulator of FN expression. CCN2 is significantly induced by Smad3, a critical mediator of TGF-β signaling. CCN2 acts as a downstream mediator of TGF-β/Smad signaling and acting synergistically with TGF-β to regulate FN gene expression. Finally, we observed that CCN2 and FN predominantly expressed in the dermis of normal human skin, stromal tissues of skin squamous cell carcinoma (SCC), and simultaneously induced in wounded human skin in vivo. These findings provide evidence that CCN2 is responsible for mediating the stimulatory effects of TGF-β/Smad on FN gene expression, and attenuation of CCN2 expression may benefit to reduce fibrotic ECM microenvironment in disease skin.

Citing Articles

Dual delivery gene-activated scaffold directs fibroblast activity and keratinocyte epithelization.

Laiva A, OBrien F, Keogh M APL Bioeng. 2024; 8(1):016104.

PMID: 38283135 PMC: 10821797. DOI: 10.1063/5.0174122.


Increased Levels of BAMBI Inhibit Canonical TGF-β Signaling in Chronic Wound Tissues.

Ehnert S, Rinderknecht H, Liu C, Voss M, Konrad F, Eisler W Cells. 2023; 12(16).

PMID: 37626905 PMC: 10453918. DOI: 10.3390/cells12162095.


CCN1 is predominantly elevated in human skin dermis by solar-simulated ultraviolet irradiation and accumulated in dermal extracellular matrix.

Qin Z, He T, Guo C, Kim J, Quan T J Cell Commun Signal. 2023; 17(2):287-296.

PMID: 37245186 PMC: 10326203. DOI: 10.1007/s12079-023-00767-6.


Fibronectin in hyperglycaemia and its potential use in the treatment of diabetic foot ulcers: A review.

Kanta J, Zavadakova A, Sticova E, Dubsky M Int Wound J. 2022; 20(5):1750-1761.

PMID: 36537075 PMC: 10088845. DOI: 10.1111/iwj.13997.


Establishment of an In Vitro Scab Model for Investigating Different Phases of Wound Healing.

Liu C, Rinderknecht H, Histing T, Kolbenschlag J, Nussler A, Ehnert S Bioengineering (Basel). 2022; 9(5).

PMID: 35621469 PMC: 9137770. DOI: 10.3390/bioengineering9050191.


References
1.
Yeger H, Perbal B . The CCN family of genes: a perspective on CCN biology and therapeutic potential. J Cell Commun Signal. 2008; 1(3-4):159-64. PMC: 2443235. DOI: 10.1007/s12079-008-0022-6. View

2.
Igarashi A, Okochi H, Bradham D, Grotendorst G . Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 1993; 4(6):637-45. PMC: 300970. DOI: 10.1091/mbc.4.6.637. View

3.
Kretschmer A, Moepert K, Dames S, Sternberger M, Kaufmann J, Klippel A . Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. Oncogene. 2003; 22(43):6748-63. DOI: 10.1038/sj.onc.1206791. View

4.
A Wahab N, Yevdokimova N, Weston B, Roberts T, Li X, Brinkman H . Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J. 2001; 359(Pt 1):77-87. PMC: 1222123. DOI: 10.1042/0264-6021:3590077. View

5.
Quan T, Shao Y, He T, Voorhees J, Fisher G . Reduced expression of connective tissue growth factor (CTGF/CCN2) mediates collagen loss in chronologically aged human skin. J Invest Dermatol. 2009; 130(2):415-24. PMC: 2877594. DOI: 10.1038/jid.2009.224. View